SeeThruEquity has issued a preliminary coverage report on United Health Products (OTCQB: UEEC). The report follows the company’s recently filed application with the FDA to expand use indications for its lead product candidate, Hemostyp®, an all-natural hemostatic agent that has demonstrated the ability to quickly control bleeding from open wounds and body cavities. Hemostyp® Topical Hemostatic Dressing is FDA approved as a Class 1 device and is sold in prescription and over-the-counter forms. If approved by the FDA, the indications for Hemostyp® would be expanded to include use in general surgery, opening a new form of revenue for the company.
To view the full press release, visit http://nnw.fm/6FtQN
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its products and increasing sales in its current markets. www.Unitedhealthproductsinc.com.
NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer